ALEXA HERZIG: Open Payments
NPI 1164077004 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,540 in 137 payments from 20 companies in 2025. Trend: 2023 $3,164 · 2024 $4,084 · 2025 $3,540
Food & beverage: $3,540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $637 |
| GENZYME CORPORATION | 16 | $545 |
| Regeneron Healthcare Solutions, Inc. | 9 | $332 |
| UCB, Inc. | 9 | $290 |
| Arcutis Biotherapeutics, Inc. | 17 | $286 |
| Incyte Corporation | 13 | $260 |
| Galderma Laboratories, L.P. | 3 | $195 |
| Novartis Pharmaceuticals Corporation | 6 | $174 |
| Botanix SB Inc | 5 | $169 |
| E.R. Squibb & Sons, L.L.C. | 5 | $162 |
Products named: DUPIXENT, BOTOX, Bimzelx, Zoryve, OPZELURA, SKYRIZI, NEMLUVIO, SOFDRA.
Industry payments across CA — which companies pay providers there.
